Wells Fargo & Company Abbott Laboratories Call Options Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $780,546 - $921,414	7,800 New	7,800 $889,000
Q2 2023 Aug 15, 2023	SELL	$100.78 - $112.29 $282,184 - $314,412	-2,800 Reduced 54.9%	2,300 $250,000
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $271,208 - $319,228	2,800 Added 121.74%	5,100 $516,000
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $218,638 - $256,496	2,300 New	2,300 $252,000
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $8.21 Million - $9.67 Million	-75,400 Reduced 65.34%	40,000 $4.79 Million
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $10.6 Million - $12.8 Million	115,400 New	115,400 $109,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.